The OncoDaily Medical Journal is launching a special series focused on Cancer in Central Asia. This series aims to provide the research, practice, and policy communities with critical insights and evidence on cancer control efforts across the diverse health systems of Central Asia. The Special Series is led by two internationally recognized leaders in the field: Dilyara Kaidarova, President of Kazakhstan Cancer Society, and Djamila Polatova, General Director of The Center of Pediatric Hematology, Oncology and Clinical Immunology of Uzbekistan. Accepted manuscripts for the special series will be fast-tracked for publication and prominently featured as part of this ongoing regional initiative.
Cancer in Central Asia
The OncoDaily Medical Journal’s special series on Cancer in Central Asia seeks to deliver a comprehensive overview of cancer control strategies, healthcare system performance, and policy implementation across countries including Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan, etc. This series highlights the unique epidemiological patterns, resource environments, and system-level challenges that characterize oncology in the region.
Focus Areas for Submissions
- Epidemiology, Prevention and Early Detection: Focuses on understanding cancer incidence and mortality trends, region-specific risk factors, and early detection gaps across Central Asian populations.Submissions are encouraged to address the role of population-based cancer registries, data completeness, and data quality as foundational tools for evidence-based cancer control and regional surveillance.
- Healthcare System Disparities: Examines how structural, economic, and geographic barriers influence access to timely diagnosis, specialized care, and essential cancer services in urban, rural, and remote areas.
- Policy, Implementation Science and Health System Strengthening: Analyses of national cancer control plans, screening initiatives, workforce development, implementation challenges, and policy innovations designed to strengthen cancer care systems across Central Asia.
- Treatment Advances and Integration: Studies on the adoption and integration of modern therapies – such as immunotherapies, targeted treatments, and advanced radiotherapy – into clinical practice across diverse healthcare settings.
- Impact of Technology and AI in Cancer Care: Exploration of how technological innovations, including artificial intelligence, telemedicine, and digital health tools, are transforming diagnosis, treatment planning, patient monitoring, and data systems in Central Asia.
- Pediatric Oncology and Rare Tumors: Encourages focused analyses on childhood cancers and rare tumors, recognizing these as high-impact yet under-resourced and vulnerable areas.
- Regional, Cross-Border and Academic Collaboration: Highlights the importance of regional and cross-border collaboration, shared clinical networks, multicenter research, and educational and academic initiatives as essential components for the sustainable development of cancer care, workforce training, and knowledge exchange across Central Asia.
Clarified Criteria for Evaluation
Manuscripts will be evaluated based on:
- Innovation – Introduction of novel approaches, tools, data, or methodologies relevant to Central Asian contexts.
- Regional Applicability – Clear relevance and potential for adaptation or scalability across the health systems of Central Asia.
- Impact on Practice or Policy – Demonstrated implications for improving cancer care delivery, health equity, or policy execution within the region.
Author Guidelines
Authors interested in submitting to the “Cancer in Central Asia in 2026” special series should adhere to the following guidelines. We particularly welcome submissions that:
- Examine how demographic, socioeconomic, and geographic factors influence the effectiveness of cancer control interventions.
- Explore the implementation of evidence-based interventions in underserved, remote, or underrepresented populations across Central Asia.
- Provide meta-analyses or comparative studies that offer generalizable findings relevant to cancer control efforts in the region.
More information about author guidelines and the submission process can be found on OncoDaily Medical Journal.
You can also find more posts featuring OncoDaily Medical Journal on OncoDaily.